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Abstract —Bilitranslocase (BTL) is a organic anion transporter expressed in liver 
and in several extra-hepatic tissues. This membrane protein transports different 
substrates as pyrrolic molecules, nucleotides, flavonoids. Anthocyanins, one of 
the most represented flavonoids class are known to have antioxidant activity. 
They act as anti-inflammatory, anti-cancer and anti-proliferative molecules by 
interfering with different intracellular pathways. Some chronic colon diseases 
results in an increase in the pro-inflammatory machinery that are associated 
with a 5-fold increased risk of developing colon cancer. The expression and the 
role of BTL in the gastrointestinal tract in normal and pathological condition, as 
well as its role as anthocyanins transporter in colon cancer cells will be take into 
account in Trans2care project. 
Index Terms — bilitranslocase, organin transporter, flavonoids, anthocyanins, 
colon cancer, chronic colon diseases
———————————————————
1 INTRODUCTION
1.1 Bilitranslocase (BTL)
Bilitranslocase (BTL) is a plasma membrane transporter of 340 amino acids that displays no homology with known proteins [1]. However, its coding sequence 
shares 96% identity with a segment of the antisense strand of ceruloplasmin. BTL 
was originally identified in rat liver, and subsequently found also in absorptive 
(stomach and intestine) and excretory (kidney) epithelia. Its sub-cellular localization 
is suitable for the uptake of its substrates from the gastro-intestinal lumen, 
suggesting its nutritional role. Concerning BTL expression in pathological conditions, 
preliminary data show reduction in its expression in kidney cancer cells. BTL has also 
been detected in colon cancer cell line Caco-2 where the transport activity is strongly 
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inhibited by anti-bilitranslocase antibodies [2]. However, there are no available data 
on the presence of this transporter in chronic colon diseases. 
Bilitranslocase transports various polyaromatic compounds such as 
bromosulfophthalein (BSP) and indocyanine green, dyes used in the evaluation of 
hepatic function, but also bilirubin and nucleotides. BTL presence in the stomach [3] 
with the functional properties identical to those in the liver [4] might explain why 
flavonoids, as dietary anthocyanins for example, are absorbed a few minutes after 
their ingestion [5]. On the other hand, BTL high turnover might explain why flavonoids 
are rapidly metabolized and excreted. The detection of BTL on the luminal surface of 
the intestinal epithelium could also speak in favor of its role in flavonoid uptake since 
they are absorbed at this level as well.
1.2 Anthocyanins and chronic bowel diseases 
Flavonoids are a large group of phytonutrients that may provide beneficial effects on human health. They are divided into several classes: flavanones, flavones, 
flavonols, flavanols and anthocyanins. The main dietary sources of flavonoids are 
fruits, vegetables and grains. Epidemiological, clinical and experimental studies have 
indicated that dietary intake of flavonoids confers protection against multiple chronic 
diseases [6]. Their possible role in cancer prevention and progression has gained 
increased attention over the last years. Anthocyanins, which are the most abundant 
flavonoid constituents of fruits and vegetables [7] might be of special interest in 
this respect. Recent data show that these compounds are excellent intracellular 
antioxidants even at very low concentrations [8] and it is their antioxidant activity 
that confers protection against carcinogenesis. However, in cells that have already 
undergone malignant transformation, anthocyanins, act as prooxidants and 
induce apoptotic death [9]. Various studies confirmed the antiproliferative and 
anticarcinogenic activities of anthocyanins in different cell lines originating from 
colorectal cancer [10, 11]. Colorectal cancer is the second most frequent cause 
of cancer-related death. A combination of various risk factors, including obesity, 
sedentary lifestyle, increased prevalence of smoking, excessive alcohol consumption, 
a diet rich in red and processed meat and low intake of fruits and vegetables, can 
trigger the carcinogenic process [12]. Anthocyanins have been shown to exert strong 
cytotoxicity on highly tumorigenic and metastatic Lovo/ADR colon cancer cell line 
while being less harmful to cells with low proliferation rate (Caco-2), which brings 
up their selective action [9]. Animal studies have also reported anticarcinogenic 
properties of anthocyanins. In induced rat colon cancer cell models they significantly 
decreased total tumors as well as aberrant crypts [13, 14]. Anthocyanins have also 
shown anti-inflammatory activity through targeting NF-ĸB pathway and COX-2 
[15], which might have implications in tumorigenesis [16]. Even more, their ability 
to inhibit matrix metalloproteinase activity [17] could additionally contribute to 
both their anticancer and anti-inflammatory action. These activities, together with 
anthocyanins antioxidant properties, might also suggest their beneficial role in 
inflammatory conditions of the small intestine and colon, such as celiac disease and 
inflammatory bowel disease (IBD), yet there are no studies confirming this hypothesis. 
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Celiac disease is an immune-mediated disorder that affects primarily the small 
intestinal mucosa. It is characterized by chronic inflammation which occurs when 
gluten-activated Th1 cells start secreting cytokines (INF-γ and TNF-α) which in turn 
activate the release of enzymes such as metalloproteinases that can damage the 
intestinal mucosa leading to atrophy of intestinal villi. The progressive destruction 
of the small intestinal mucosa causes malabsorption, and a variety of clinical 
manifestations. Ulcerative colitis (UC) and Crohn’s disease (CD) are the two main 
forms of inflammatory bowel disease. They are multifactorial conditions, where both 
genetic and environmental components play their parts. However, at the basis of 
UC and CD lays aberrant immune response and consequent inflammation regulated 
mainly by NF-ĸB. Both CD and UC are associated with a 5-fold increased risk of 
developing colon cancer [18].
2 AIMS IN TRANS2CARE PROjECT
Concerning the importance of diet on human health and the still scarce knowledge of the role of anthocyanins and bilitranslocase in both physiological and pathological 
conditions of the gastrointestinal tract, we will try to:
A) Set dietary guidelines (based on the molecular mechanisms underlying 
anthocyanins bioavailability: their membrane transport at the level of the epithelial 
barrier of the gastrointestinal mucosa, and the role of BTL in it) for the prevention 
of chronic disorders of the intestine ;
B) Study and exploit the drug transport potential of BTL in order to develop new 
orally-deliverable drugs on the basis of bilitranslocase substrate specificity;
C) Exploit BTL as a biomarker: it might be an indicator of cell health (intactness), 
whereas its expression might be lost in cancer. It would be interesting to see how 
early the loss of expression occurs in disease development.
To reach these aims we will work in collaboration with IRCCS Burlo Garofalo (PP9), 
taking advantage of their tissue bank and expertise in gut histopathology in order to 
study BTL expression and determine any changes depending on the state of mucosa; 
with University of Nova Gorica (PP3), who has at its disposal sophisticated techniques 
for  anthocyanins separation and analysis in order to measure their uptake and 
transport across different cell monolayers; and with ZTM (PP10), who can help us to 
prepare a monoclonal antibody against BTL for immunohistochemistry procedures. 
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